Luyan Pharma Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -0.75% vs -1.17% in Dec 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 9.09% vs -6.92% in Dec 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5,351.00",
          "val2": "5,391.30",
          "chgp": "-0.75%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "139.70",
          "val2": "173.60",
          "chgp": "-19.53%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "39.40",
          "val2": "43.30",
          "chgp": "-9.01%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "66.00",
          "val2": "60.50",
          "chgp": "9.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "26.10%",
          "val2": "25.30%",
          "chgp": "0.08%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 3.78% vs 3.16% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -19.76% vs -4.61% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "21,220.00",
          "val2": "20,447.60",
          "chgp": "3.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "720.40",
          "val2": "821.00",
          "chgp": "-12.25%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "187.60",
          "val2": "214.50",
          "chgp": "-12.54%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "7.00",
          "val2": "3.50",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "279.00",
          "val2": "347.70",
          "chgp": "-19.76%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "27.00%",
          "val2": "33.20%",
          "chgp": "-0.62%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

5,351.00

5,391.30

-0.75%

Operating Profit (PBDIT) excl Other Income

139.70

173.60

-19.53%

Interest

39.40

43.30

-9.01%

Exceptional Items

0.00

0.00

Consolidate Net Profit

66.00

60.50

9.09%

Operating Profit Margin (Excl OI)

26.10%

25.30%

0.08%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is -0.75% vs -1.17% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is 9.09% vs -6.92% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

21,220.00

20,447.60

3.78%

Operating Profit (PBDIT) excl Other Income

720.40

821.00

-12.25%

Interest

187.60

214.50

-12.54%

Exceptional Items

7.00

3.50

100.00%

Consolidate Net Profit

279.00

347.70

-19.76%

Operating Profit Margin (Excl OI)

27.00%

33.20%

-0.62%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 3.78% vs 3.16% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -19.76% vs -4.61% in Dec 2024

All Annual Results